Matthew Strobeck
CIK 1377832 · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.01M
Companies
5
Total Filings
88
Lifetime Open-Market Net
$11.83M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QDEL | Director | 51,234 | $13.75 | $704.5K | $1.52M | 21 | 2026-06-02 |
| BDSX | Director | 133,096 | $24.86 | $3.31M | $6.89M | 18 | 2026-01-06 |
| Accelerate Diagnostics, Inc (AXDX) Delisted | Director | 323,238 | $0.03 | $11.0K | $2.67M | 24 | 2024-01-25 |
| YIELD10 BIOSCIENCE, INC. (MBLX) Delisted | Director | 66,664 | — | — | $752.6K | 23 | 2016-01-28 |
| SANTARUS INC (SNTS) Delisted | Director | — | — | — | $0 | 1 | 2012-05-16 |
Recent Filings · Page 9 of 9
88 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-03-12 | YIELD10 BIOSCIENCE, INC. (MBLX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-07-14 | YIELD10 BIOSCIENCE, INC. (MBLX) Delisted | Gift (G) | +14,185 | $0 | EDGAR |
| 2010-06-08 | YIELD10 BIOSCIENCE, INC. (MBLX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-06-05 | YIELD10 BIOSCIENCE, INC. (MBLX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-12-17 | YIELD10 BIOSCIENCE, INC. (MBLX) Delisted | Buy (P) | +40,000 | $318.0K | EDGAR |
| 2008-06-09 | YIELD10 BIOSCIENCE, INC. (MBLX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-06-14 | YIELD10 BIOSCIENCE, INC. (MBLX) Delisted | Sell (S) | −40,865 | -$851.7K | EDGAR |
| 2007-05-29 | YIELD10 BIOSCIENCE, INC. (MBLX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 81–88 of 88
Prev
Page 9 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.